Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
459,483
-
Share change
-
-333,971
-
Total reported value
-
$353,008
-
Price per share
-
$0.77
-
Number of holders
-
15
-
Value change
-
-$473,358
-
Number of buys
-
4
-
Number of sells
-
18
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q3 2018
As of 30 Sep 2018,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
459,483 shares.
The largest 10 holders included
Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PANAGORA ASSET MANAGEMENT INC, NORTHERN TRUST CORP, A.R.T. Advisors, LLC, TWO SIGMA SECURITIES, LLC, GOLDMAN SACHS GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.